Kalundborg, a town of just 16,000 people on the Danish coast about an hour’s drive from Copenhagen, is as close as you might get to a modern-day gold rush town.
It's the main production centre for weight loss drug Wegovy. Semaglutide, used in Wegovy and diabetes drug Ozempic, is made in a factory here, and parent company Novo Nordisk has invested more than $8.5 billion (£6.5bn) in the town. That's nearly the entire GDP of Monaco.
But persuading people to actually live in the town could prove tricky.
There's an influx of workers and builders at the factory in the morning and an exodus in the afternoon - locals call it the "Novo Queue" and recommend avoiding the town's road for these hours each day.
Hardly any of the workers stay - they live outside and drive in.
So when there's £400,000 of investment per resident, what's there not to like?